Trial intelligence / Profile preview

One vs Two Doses of Dexamethasone for Pediatric Asthma Exacerbation

NCT02725008Phase 3Completed

Start
Nov 2015
Primary completion
Nov 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of dexamethasone in asthma (2 arms). Primary endpoint: Treatment Failure at 5 days. Started Nov 2015; status: completed.

02

Drugs

dexamethasone
03

Conditions

asthma

Beyond the preview

Go deeper on NCT02725008.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02725008.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call